AlphAIalphai — Financial news for AI agents
Stock TitanMAR 312 min read$SNYR

Synergy CHC pushes earnings release and investor call to April 1

Synergy CHC Corp. (NASDAQ: SNYR) has announced a revised date for its fourth quarter and full-year 2025 financial results, moving the release to Wednesday, April 1, 2026, before market open. A conference call with CEO Jack Ross and CFO Jaime Fickett will follow at 9:00 a.m. ET. The company will discuss its financial performance and provide updates to investors during the call.

Original reporting
Stock Titan
Published Mar 31, 2026, 3:40 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 31, 2026, 4:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Synergy CHC pushes earnings release and investor call to April 1 — source image
Source · Stock Titan
Decision brief

The 30-second read

$SNYRNeutralMed
01

Why it matters

The earnings report could serve as a catalyst for short-term trading opportunities, depending on the results.

02

Market read

High relevance due to scheduled earnings release; significant for traders and investors monitoring the company's performance.

03

What to watch

Potential macroeconomic factors or regulatory changes could influence stock performance independently of earnings.

Timing: High, as the event is scheduled for April 1, 2026, before market open.

Background

Synergy CHC Corp. is preparing to release its Q4 and full-year 2025 financial results, which are highly anticipated by investors.

Company-level read

Ticker impact

$SNYRNeutralMedium confidence
Context

High relevance due to upcoming earnings release and investor call.

Expected impact

Potential for short-term volatility; possible upward movement if earnings surpass expectations.

Evidence & confidence

Market often reacts strongly to earnings reports. As the date approaches, traders should monitor pre-release sentiment and analyst estimates.

Market effects

Sector

Financial performance of SNYR may influence sector sentiment, especially within healthcare and biotech sectors.

Regional

Limited regional impact; primarily affects investors in the company's primary markets.

Global

Minimal global market relevance unless earnings significantly deviate from expectations.

Counterpoint

What could challenge this read

Earnings may underperform due to industry headwinds, leading to a decline in stock price.

Key entities

  • Company
    Synergy CHC Corp.

    A healthcare company listed on NASDAQ.

  • CEO
    Jack Ross

    Chief Executive Officer of Synergy CHC.

  • CFO
    Jaime Fickett

    Chief Financial Officer of Synergy CHC.

Read at source← All news

Related articles

AUG 8
$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).

fool.com6 min
AUG 8
$BWAMed

Why Is BorgWarner (BWA) Expanding Its Edge In China And EV Systems?

BorgWarner (NYSE:BWA) said it won new variable cam timing system contracts in Europe and China, including a conquest award, and that the wins expand positions with existing customers and replace a competitor on a China program. It also received awards for high voltage inverters and integrated drive modules for hybrid and EV platforms, which it said add to backlog.

simplywall.st4 min
AUG 8
$AVAVMedAI 8/10

Bloomberg: US to purchase anti-drone lasers for $400 million

Bloomberg reports the Pentagon will buy laser-based counter-drone systems from AeroVironment Inc. in a deal valued at at least $400 million. The contract is expected to supply the Army with dozens of Locust systems, described as an AI-enabled laser system for tracking and disabling small and medium UAVs. AeroVironment shares rose 8.1% intraday, according to the report.

news.liga.net4 min